Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$634,818
-$1,863,694 QoQ
Shares Held
39,976
-78.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#369
of 1,016 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
36,078 | $2,592,565 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
12,619 | $2,126,806 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,861 | $2,092,005 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
37,994 | $1,287,236 | |
| 5 | HLN |
Haleon plc
|
133,508 | $1,245,629 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
21,721 | $753,067 | |
| 7 | VTRS |
Viatris Inc
This page
|
39,976 | $634,818 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
16,739 | $605,951 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,818 | 39,976 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,498,512 | 184,938 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $1,219,838 | 97,979 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $768,348 | 77,611 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $701,112 | 78,512 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $226,921 | 26,053 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $384,904 | 30,916 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $308,570 | 26,578 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $167,135 | 15,723 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $253,032 | 21,192 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $246,718 | 22,781 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $218,872 | 22,198 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $225,488 | 22,594 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $218,027 | 22,664 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $191,246 | 17,183 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $212,425 | 20,289 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $218,263 | 20,061 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $263,158 | 19,450 | Shares | Sole | 2022-02-17 | |
| 2021-06-30 | $206,018 | 14,417 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $190,592 | 13,643 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $321,747 | 17,169 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||